CLINICAL_TRIALS
trial_result
· 2020-11-06
Clinical Trial Update: Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation [Phase 2]
Summary
A Phase 2 study evaluating ranolazine and dronedarone, alone and in combination, in patients with paroxysmal atrial fibrillation; the trial is completed with re…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2020-11-06